KV Pharmaceutical Completes Reorganization
K-V Pharmaceutical announced that its plan of reorganization is effective and that it successfully emerged from Chapter 11 with significantly reduced debt and a $375 million recapitalization.
September 16, 2013
Capital Ventures International | Deutsche Bank | Greywolf Capital | Jefferies | K-V Pharmaceutical | Kingdon Capital | Silver Point Finance | Willkie Farr & Gallagher
ABF Journal